Core Viewpoint - In 2025, the National Market Supervision Administration handled a total of 44,521 advertising violation cases, imposing fines totaling 252 million yuan, effectively strengthening consumer rights protection. Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding eye health products, including misleading statements about preventing myopia and promoting false endorsements from international ophthalmologists [1]. - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for advertising camel milk powder with false claims related to health benefits and misleading promotional content [2]. - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising ceramic tableware as being produced in Jingdezhen [3]. - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising organic perilla seed oil with unverified health claims [4]. - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting various health products with exaggerated claims about their efficacy [5]. - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising eye health patches with unsubstantiated claims about restoring vision [6][7]. - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising related to real estate development [8]. - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and making false health claims [9]. - Songyuan Anorectal Hospital was fined 100,000 yuan for misleading advertising regarding its medical qualifications [10]. - Yunnan Yuyao Biological Pharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations for prescription drugs [10]. Group 2: Regulatory Actions - In 2025, the National Market Supervision Administration launched a nationwide campaign to rectify advertising market order, focusing on key areas such as healthcare, pharmaceuticals, medical devices, food, and children's vision protection [10].

Core Viewpoint - The article emphasizes the need for stricter regulation of misleading advertisements related to "miracle doctors" and "miracle drugs," particularly in the context of new media and online platforms, to protect consumer health and safety [1][2]. Group 1: Regulatory Actions - The National Market Regulatory Administration has issued a notice to rectify advertising market order, specifically targeting misleading health claims that guarantee cures for serious illnesses [1]. - There is a call for enhanced platform responsibility, including a pre-approval mechanism for health-related content and improved advertising identification systems [3]. Group 2: Advertising Tactics - New marketing strategies, such as soft articles, live streaming, and AI-generated virtual personas, are being used to subtly promote health products, making it difficult for consumers to discern the truth [1][2]. - Advertisements are increasingly tailored using big data to target specific demographics, such as the elderly or parents of students, exploiting consumer trust in the platforms [2]. Group 3: Legal and Consumer Protection - The article highlights the need for legal reforms to address advertising practices in the medical and health sectors, including the establishment of a "blacklist" for violators and improved consumer redress mechanisms [4]. - It stresses the importance of increasing penalties for violations and clarifying legal ambiguities to enhance consumer protection [4].